nevro - search results

If you're not happy with the results, please do another search

Nevro receives US FDA approval for Senza Omnia spinal cord stimulation system

  Nevro has received approval from the US Food and Drug Administration (FDA) for the Senza Omnia spinal cord stimulation system to treat chronic pain....
Senza

Nevro receives TGA approval for Senza II spinal cord stimulation system delivering HF10 therapy

The Therapeutic Goods Administration (TGA) has granted approval to Nevro for its next-generation Senza II spinal cord stimulation system delivering the company’s proprietary HF10...

Nevro receives expanded MR-conditional labelling for Senza system in Europe and Australia

Senza is the first implantable spinal cord stimulator system that is 3 Tesla MRI-compatible.

Nevro receives FDA approvable letter for Senza spinal cord stimulation system

According to the approvable letter, approval of the PMA is subject to satisfaction of regulatory inspections and audits of manufacturing facilities, methods and controls for Senza.

Michael Enxing appointed Vertiflex vice president, chief commercial officer

Michael Enxing has been appointed as vice president and chief commercial officer of Vertiflex. Enxing will be responsible for leading the company’s sales, marketing,...

Novel spinal neuromodulation device relieves pain in low back pain patients

After six months of using the Nevro system device in 30 patients, the average back and leg pain visual analog scores fell to 1.6 from eight and six (out of ten) respectively, according to researchers from the Guy's & St Thomas' Hospital, London, UK.

Tim Pigott

Ronald Bartels

Matthew Scott-Young